학술논문
Erciyes Clinical Guideline for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19
Clinical Guideline
Clinical Guideline
Document Type
Report
Author
Source
The Journal of Pediatric Academy. December 2022, Vol. 3 Issue 3, p87, 8 p.
Subject
Language
English
Abstract
Introduction and Purpose SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) causes acute and post-acute illness in the pediatric population. One of the post-acute illnesses is Multisystem Inflammatory Syndrome in Children [...]
Multisystem Inflammatory Syndrome in Children (MIS-C) is an inflammatory response to prior SARS-CoV-2 infection. Clinical features of MIS-C could resemble those seen in other diseases, including Kawasaki Disease, Hemophagocytic Lymphohistiocytosis, and cardiovascular shock. The pathogenesis is unclear; however, it is thought to develop 4 to 6 weeks after infection. This guideline aims to provide a framework for physicians to use to evaluate patients and manage those diagnosed with MIS-C. Keywords: Pediatric, COVID-19, MIS-C, guideline
Multisystem Inflammatory Syndrome in Children (MIS-C) is an inflammatory response to prior SARS-CoV-2 infection. Clinical features of MIS-C could resemble those seen in other diseases, including Kawasaki Disease, Hemophagocytic Lymphohistiocytosis, and cardiovascular shock. The pathogenesis is unclear; however, it is thought to develop 4 to 6 weeks after infection. This guideline aims to provide a framework for physicians to use to evaluate patients and manage those diagnosed with MIS-C. Keywords: Pediatric, COVID-19, MIS-C, guideline